14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:DPRX
Delisted

Dipexium Pharmaceuticals Fund Signals

$1.34
+0 (+0%)
At Close: Jan 16, 2018

Latest Data & Signals Issued

Signal Type Signal Value Data
Score 0.000 40 days ( 0 % )
Last Price $1.34 0 %
High/ Low $1.34 - $1.34 0%
Chg 7 Days N/A $1.34 $1.34
Chg 30 Days N/A $1.34 $1.34
Chg 12 mos -16.25 % $1.60 $1.34
Trend - 3 mos N/A Width: 0 %
Trend - 12 mos -1.52 % Width: 28.12 %
Pred. range - 3 mos N/A - N/A -100.00 % - -100.00 %
Pred. range - 12 mos $1.07 - $1.37 -20.39 % - 1.99 %
Short MA avg 3 mos Sell Nov 30, -1 - N/A days
Long MA avg 3 mos Sell Jan 08, 2018 - 7 days
Short/Long MA avg 3 mos Sell Jan 08, 2018 - 7 days
Short MA avg 12 mos Buy Apr 18, 2017 - 69 days
Long MA avg 12 mos Buy Nov 20, 2017 - 38 days
Short/Long MA avg 12 mos Buy Nov 21, 2017 - 37 days
Pivot Short Sell Jan 15, 2018 - 2 days
Bollinger Sell Nov 30, -1 - N/A days
MACD N/A No Dates Stored For This Signal
Click to get the best stock tips daily for free!

About Dipexium Pharmaceuticals

Dipexium Pharmaceuticals, Inc., a late stage pharmaceutical company, focuses on the development and commercialization of antibiotics in the United States. It develops Locilex (pexiganan cream 0.8%), a novel, broad spectrum, and topical antibiotic, which is in Phase 3 clinical trials for the treatment of mild infections of diabetic foot ulcers. The company was founded in 2010 and is based in New York, New York.... DPRX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT